CompaniesPin Therapeutics

Pin Therapeutics

active
Seongnam, Korea
Founded 2017
Website
About

Protein Degradation Therapeutics

Areas of Focus

Categories

Small Molecule Pharmaceutical
Clinical Trials (7)
View all

Total Trials

7

As Lead Sponsor

7

As Collaborator

0

Total Enrollment

860

By Phase

PHASE3: 2PHASE2: 5

By Status

COMPLETED: 4TERMINATED: 3

Recent Trials

NCT00290017Lead Sponsor
Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
PHASE3Terminated
400 participants
Started: Feb 28, 2006
NCT00243204Lead Sponsor
Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
PHASE3Terminated
400 participants
Started: Jan 31, 2006
NCT00080080Lead Sponsor
Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung Cancer
PHASE2Completed
NCT00083239Lead Sponsor
Study of Talabostat in Advanced Melanoma
PHASE2Completed
NCT00083252Lead Sponsor
Study of Talabostat and Cisplatin in Advanced Melanoma
PHASE2Completed
View all 7 trials →
Locations (1)
Headquarters
Seongnam, Korea
Map

Loading map...